1. Home
  2. CERE

as 06-12-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Cerevel Therapeutics Holdings Inc is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. It has a diversified pipeline comprising five clinical-stage investigational therapies and several preclinical compounds with the potential to treat a range of neuroscience diseases, including schizophrenia, epilepsy, Parkinson's disease and substance use disorder. Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.

Founded: 2018 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 7.5B IPO Year: N/A
Target Price: $42.67 AVG Volume (30 days): 1.2M
Analyst Decision: Hold Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.73 EPS Growth: N/A
52 Week Low/High: $19.59 - $43.59 Next Earning Date: 08-01-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

CERE Daily Stock ML Predictions

Stock Insider Trading Activity of Cerevel Therapeutics Holdings Inc. (CERE)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
COLES N ANTHONY CERE Director Apr 1 '24 Sell $42.33 50,000 $2,116,640.00 15,638 SEC Form 4
COLES N ANTHONY CERE Director Mar 4 '24 Sell $41.01 50,000 $2,050,550.00 15,638 SEC Form 4
COLES N ANTHONY CERE Director Feb 29 '24 Sell $41.16 50,000 $2,057,890.00 15,638 SEC Form 4
Renger John CERE Chief Scientific Officer Feb 6 '24 Sell $41.54 2,161 $89,776.80 6,370 SEC Form 4
COLES N ANTHONY CERE Director Feb 6 '24 Sell $41.54 2,506 $104,109.51 15,638 SEC Form 4
COLES N ANTHONY CERE Director Jan 2 '24 Sell $42.24 50,000 $2,111,815.00 2,704 SEC Form 4
Bodenrader Mark CERE See Remarks Dec 19 '23 Sell $41.42 7,889 $326,787.62 17,724 SEC Form 4
DiPietro Kenneth CERE Chief Human Resources Officer Dec 19 '23 Sell $41.42 6,256 $259,143.54 24,663 SEC Form 4
Tregoning Kathleen CERE See Remarks Dec 19 '23 Sell $41.42 6,288 $260,469.08 7,516 SEC Form 4
ALTSCHULLER Susan CERE Chief Financial Officer Dec 19 '23 Sell $41.42 13,808 $571,971.55 16,913 SEC Form 4
Sanchez Ramiro CERE Chief Medical Officer Dec 19 '23 Sell $41.42 10,152 $420,528.33 14,673 SEC Form 4
Akamine Scott CERE Chief Legal Officer Dec 19 '23 Sell $41.42 7,072 $292,944.87 7,237 SEC Form 4
Sanchez Ramiro CERE Chief Medical Officer Dec 15 '23 Sell $41.39 7,500 $310,392.75 0 SEC Form 4
Sanchez Ramiro CERE Chief Medical Officer Dec 7 '23 Sell $41.37 10,000 $413,700.00 0 SEC Form 4
Akamine Scott CERE Chief Legal Officer Dec 5 '23 Sell $35.00 7,500 $262,500.00 513 SEC Form 4
Akamine Scott CERE Chief Legal Officer Dec 5 '23 Sell $41.37 10,000 $413,700.00 513 SEC Form 4
COLES N ANTHONY CERE Director Nov 14 '23 Sell $25.13 22,824 $573,455.28 2,704 SEC Form 4
COLES N ANTHONY CERE Director Nov 7 '23 Sell $25.02 27,076 $677,555.24 2,704 SEC Form 4
COLES N ANTHONY CERE Director Nov 7 '23 Sell $25.16 100 $2,516.00 2,704 SEC Form 4
COLES N ANTHONY CERE Director Nov 2 '23 Sell $25.19 38,599 $972,239.33 2,704 SEC Form 4
COLES N ANTHONY CERE Director Nov 2 '23 Sell $25.43 61,401 $1,561,458.13 2,704 SEC Form 4

Share on Social Networks: